South­ern Cal­i­for­nia Doc­tors are Suc­cess­ful When Vi­a­gra ® Fails

Los Angeles Times - - BASEBALL: MARINERS 4, ANGELS 1 -

Physi­cians at lo­cal med­i­cal of­fices are so con­fi­dent their treat­ment will help men with erec­tile dys­func- tion, they are of­fer­ing the first 25 callers a free in-of­fice med­i­ca­tion dose. Erec­tile dys­func­tion and pre­ma­ture ejac­u­la­tion con­tinue to be a prob­lem for mil­lions of men, in spite of the pop­u­lar­ity of Vi­a­gra ® and sim­i­lar drugs. Many men don’t see re­sults with th­ese pills or can­not take them due to ad­verse side ef­fects. Bos­ton Med­i­cal Group blends per­son­al­ized combi- na­tions of FDA ap­proved med­i­ca­tions for each pa­tient. “That’s why our suc­cess rate is 98%,” says Dr. Wil­liam Livingston, Board Cer­ti­fied Urol­o­gist. “We help men as old as ninety-eight, with di­abe- tes, heart con­di­tions and post prostate surgery. Even in hard to treat cases our re­sults ev­ery­day are amaz­ing.” The pro­pri­etary treat­ment has been used by BMG doc­tor’s to help over a mil­lion men world-wide. “We ad­just the pre­scrip­tion to main­tain an erec­tion up to 45-min­utes or longer based on in­di­vid­ual pref­er­ence” says Dr. Livingston, “and pa­tients see re­sults right in our of­fice. Af­ter cli­max the pa­tient stays erect, this al­lows them to ad­e­quately sat­isfy their part­ner. No other med­i­ca­tion can do this. We of­fer a sim­ple guar­an­tee: If you don’t re­spond to the med­i­ca­tion on the first visit the of­fice visit is free.” With that guar­an­tee, lo­cal pa­tients have noth­ing to lose. Open­ings are fill­ing quickly for the free in-of­fice med­i­ca­tion dose, and af­ter that, the nor­mal fees will be charged. Pa­tients are as­sured of con­fi­den­tial­ity with pri­vate wait­ing rooms and a pro­fes­sional staff. More in­for­ma­tion is avail­able by call­ing (877) 657-5874. Bos­ton Med­i­cal Group has of­fices in Los An­ge­les, Or­ange County and San Diego. Bos­tonMed­i­calGroup.com

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.